Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

New Breath Condensate Testing Approach Enhances Reliability for COPD Monitoring

By HospiMedica International staff writers
Posted on 06 Nov 2026

Chronic obstructive pulmonary disease (COPD) is a progressive lung condition that can increasingly impair breathing over time. More...

Diagnosis and monitoring may be burdensome because patients often require blood tests or costly imaging such as CT scans, while flare-ups can occur unexpectedly and worsen rapidly. To support less invasive monitoring, researchers have developed a new approach designed to improve the reliability of exhaled breath condensate testing.

Engineers at the University of Notre Dame are studying exhaled breath condensate (EBC) measurement as a noninvasive approach for monitoring pulmonary disease. EBC testing collects and cools a patient’s exhaled breath, then analyzes the resulting liquid condensate for biomarkers. The method uses affordable, portable point-of-care equipment and could reduce reliance on blood draws in both clinical and remote settings.

A major challenge has been poor consistency between repeated EBC measurements. Rather than attributing this variation mainly to biological differences, the research team investigated whether physical phase changes during sample collection contribute to biomarker loss. The work focused on co-condensation, which influences how biomarkers enter droplets as they form, and evaporation, which determines how much target compound is lost to the air during collection and processing.

Using a custom-built fluorescence measurement platform, the researchers visualized droplet-level transport during EBC sampling. The study, published in Nano Letters, showed that EBC droplets can lose substantial biomarker content within a single breath cycle because of evaporation. The team developed a mathematical model to quantify biomarker loss in individual droplets and then extended it to the larger droplet population expected on a condenser surface.

Experiments designed to mimic patient sample collection showed that droplet size played a major role in biomarker loss. Longer pauses between breaths were also associated with greater evaporative losses. Ambient temperature, humidity, and collection plate temperature were identified as additional variables for further study as the researchers work toward more standardized and reproducible EBC collection.

“This is a promising first step, demonstrating that there are concrete and measurable sources of error in EBC collection shows us that we have a shot at creating a standardization system that allows clinicians to reliably use EBC in disease diagnosis. The next step in that process is to separate the different parameters that control the variation so that we can create that system,” said Amio Ritwik, doctoral student in the Interfacial Thermofluids Laboratory and lead author of the paper. 

Related Links
University of Notre Dame


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Pediatric Mask
Respire SOFT
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image Credit: Shutterstock

Explainable AI Examines Sepsis Mortality Risk and Emergency Care Delays

Preventing sepsis-related deaths in emergency departments (EDs) remains challenging because patient deterioration can result from multiple rapidly evolving and interconnected factors. These include triage... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image: A new automated approach could help predict which patients with dystonia will benefit from deep brain stimulation before surgery (Image Credit: Adobe Stock)

AI Uses Routine MRI to Predict Deep Brain Stimulation Response in Dystonia

Dystonia is a debilitating neurological movement disorder characterized by involuntary muscle contractions that cause abnormal movements and postures. Deep brain stimulation (DBS) is one of the few treatments... Read more

Health IT

view channel
Image Credit: Shutterstock

Telemonitoring Program Improves Quality of Life After Heart Failure Discharge

Heart failure is a chronic condition associated with high mortality, frequent hospitalizations, and reduced quality of life. Patients face particularly high risks of readmission and death after discharge,... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.